The healthcare giant looks expensive on today’s numbers, but a patient investor is effectively buying it at a significant discount to that price.
At a glance, UnitedHealth (UNH) stock looks pricey. Trading at about 31.9 times its last twelve months of reported earnings, it carries the kind of premium that makes many investors stop looking. But that headline number is a rearview mirror. The more telling price tag is the one you pay for the earnings analysts expect down the road.
The Discount Patience Buys You
On the earnings Wall Street expects by 2027, today’s price of $423.56 is no longer 31.9 times earnings, but about 19.0 times. That’s a 40% lower multiple. This is the forward valuation discount: as…
